tradingkey.logo
tradingkey.logo
Search

SINTX Technologies Inc

SINT
Add to Watchlist
2.265USD
-0.135-5.63%
Close 05/15, 16:00ETQuotes delayed by 15 min
9.33MMarket Cap
LossP/E TTM

SINTX Technologies Inc

2.265
-0.135-5.63%
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-5.63%

5 Days

-3.62%

1 Month

-15.49%

6 Months

-28.10%

Year to Date

-41.32%

1 Year

-28.32%

Key Insights

SINTX Technologies Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is good.Its valuation is considered fairly valued, ranking 137 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 11.00.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

SINTX Technologies Inc's Score

Industry at a Glance

Industry Ranking
137 / 206
Overall Ranking
350 / 4482
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

SINTX Technologies Inc Highlights

StrengthsRisks
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.02M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.02M.
Undervalued
The company’s latest PE is -0.41, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 330.20K shares, decreasing 38.13% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 1.15K shares of this stock.

Analyst Rating

Based on 2 analysts
Buy
Current Rating
11.000
Target Price
+362.18%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

SINTX Technologies Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

SINTX Technologies Inc Info

SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Ticker SymbolSINT
CompanySINTX Technologies Inc
CEOOlson (Eric K)
Websitehttps://sintx.com/
KeyAI